---  
layout: startup_page  
title: "AvenCell Therapeutics"  
id: "avencell.com"  
permalink: "/avencelltherapeuticsavencell.com10222024/"  
website: "https://www.avencell.com/"  
funding_round: "Series B"  
funding_amount: "$112M"  
investors: "Novo Holdings, F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, NYBC Ventures, Blackstone Life Sciences"  
about: "AvenCell Therapeutics is a clinical-stage cell therapy company focused on developing autologous and allogeneic switchable CAR-T cell therapies. Their proprietary universal platform allows for the safe and effective treatment of hematologic malignancies and autoimmune diseases by enabling rapid on/off switching of CAR-T cells even after administration. This technology addresses unmet medical needs in areas like relapsed/refractory AML."  
markets: "Cell Therapy, Oncology, Immunology, Health Care"  
hq: "Watertown, Massachusetts, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/avencell/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/avencell"  
pitchbook: ""  

date_display: "22-Oct-2024"  
date: "2024-10-22"

# SEO Optimization  
meta_title: "AvenCell Therapeutics - Series B Funding ($112M)"  
meta_description: "AvenCell Therapeutics, AvenCell Therapeutics is a clinical-stage cell therapy company focused on developing autologous and allogeneic switchable CAR-T cell therapies. Their ..."  
meta_keywords: "AvenCell Therapeutics, Cell Therapy, Oncology, Immunology, Health Care, Series B funding"  
canonical_url: "https://startup.projectstartups.com/avencelltherapeuticsavencell.com10222024/"  
---